Our Science Team

Our Science Team

In 2018, Beyond Celiac announced the hiring of Marie Robert, M.D. as Chief Scientific Officer. Dr. Robert leads the development and implementation of a transformational patient-centered research agenda focused on accelerating solutions toward new pharmaceutical treatments and a cure for celiac disease. She develops and establishes research and funding priorities and will translate the Beyond Celiac Research Consortium findings to impact patients in areas including clinical decision-making about diagnosis, disease management, treatment, and eventually a cure.

Read more about the Beyond Celiac Science Plan, spearheaded by Dr. Robert.


The Beyond Celiac Science Team

Marie Robert, M.D., Chief Scientific Officer

Dr. Robert is a nationally recognized gastrointestinal (GI) liver and pancreatic surgical pathologist with 25 years of experience in clinical diagnosis, teaching and collaborative scientific endeavors across a wide spectrum of diseases, including inflammatory and neoplastic conditions of the GI tract.

Dr. Robert will lead the development and implementation of a transformational patient-centered research agenda focused on accelerating solutions toward new pharmaceutical treatments and a cure for celiac disease. She will develop and establish research and funding priorities and will translate the Beyond Celiac Research Consortium findings to impact patients in areas including clinical decision-making about diagnosis, disease management, treatment, and eventually a cure.

Kate Avery, MPH, Director of Research and Patient Engagement

Kate supports and engages patients and caregivers who share their experiences and stories with us in pursuit of increased diagnosis and improved disease management and treatment. She has worked on multiple qualitative and quantitative research projects focused on understanding the diagnostic and disease management experience and has long been interested in health communications and the patient journey.

 

 

Amy Ratner, Medical and Science News Analyst

With over two decades of experience in journalism, much of it centered around gluten-free living, Amy Ratner joined the Beyond Celiac team in 2016 to bring the latest celiac disease updates to the masses. She regularly reports on and curates the latest in celiac disease research and shares it in patient- and community-friendly language.

 

 

 


The Beyond Celiac Scientific and Medical Advisory Panels

Beyond Celiac has worked with experts in the field of celiac disease through its Medical Advisory Council since its founding. Established in 2003, the Beyond Celiac Medical Advisory Council has played an integral role in establishing and maintaining evidence-based standards for the organization and represents the very best in scientific and medical practice. In 2019, Beyond Celiac expanded its scope of expertise by creating its Scientific Advisory Council as one of the first steps in meeting the goal of finding new treatments and a cure for celiac disease. This new scientific advisory council includes celiac disease, immunology and drug development experts.

The Scientific Advisory Council

Bob Beall, Ph.D., Beyond Celiac board member and former president and CEO of the Cystic Fibrosis Foundation

Under Beall’s 21 years of leadership, the Cystic Fibrosis Foundation applied innovative approaches to bring new therapies to patients. The life expectancy of those with cystic fibrosis rose dramatically and nearly 30 drugs were in development to treat all aspects of the disease, including its underlying cause.

Gail Hecht, M.D., professor of medicine and microbiology/immunology and chief of gastroenterology and nutrition at Loyola University, Chicago

Hecht focuses her research on host–pathogen interactions, supported through funding from the U.S, National Institutes of Health (NIH) and the Department of Veterans Affairs. She also has an interest in the gut microbiome and its impact on intestinal function and health, serving as editor-in-chief of the journalGut Microbes. Hecht is a former president of the American Gastroenterological Association.

Edwin Liu, M.D., director of the Colorado Center for Celiac Disease at Children’s Hospital Colorado and professor of pediatrics, gastroenterology, hepatology and nutrition, University of Colorado School of medicine

Liu is a practicing pediatric gastroenterologist at Children’s Hospital Colorado and a lead researcher of celiac disease in children. He recently published a study that showed an increase in prevalence in celiac disease in children and helped further understanding of celiac disease screening. Liu also studies the link between celiac disease and other autoimmune diseases, such as Type 1 diabetes.

Daniel Leffler, M.D., director of research, Celiac Center at Beth Israel Deaconess, associate professor of medicine, Harvard Medical School, and medical director, Takeda Pharmaceuticals

Leffler is a practicing gastroenterologist and celiac disease expert. He has published numerous articles about celiac disease and participates in clinical and translational research. He has been the recipient of a career development grant from the NIH, as well as multiple foundation and industry sponsored grants. He lectures nationally and internationally and co-authored the bookReal Life with Celiac Disease. Troubleshooting and Thriving Gluten Free.

Stephen Miller, Ph.D., director of the interdepartmental immunobiology center at Northwestern University Feinberg School of Medicine and research professor of microbiology-immunology

Miller is internationally recognized for his research on pathogenesis and regulation of autoimmune diseases. His work has enhanced understanding of the immune inflammatory processes underlying chronic autoimmune disease such as multiple sclerosis, type 1 diabetes, and celiac disease and could lead to potential treatments for these and other autoimmune diseases.

Joseph Murray, M. D., professor of medicine at the Mayo Clinic and a gastroenterologist in the division of gastroenterology and hepatology, department of internal medicine

Murray is a practicing gastroenterologist and leading authority in celiac disease, having published more than 100 research articles. He focuses on clinical epidemiology of celiac disease, the role of genetics in predicting disease, the development of animal models for the disease and dermatitis herpetiformis. Murray also studies the complications of celiac disease, including small bowel cancer. His research has been funded by the NIH.

Kari Nadeau, M.D., professor of pediatric food allergy, immunology and asthma and director of the Sean N. Parker Center for Allergy and Asthma Research, Stanford University

Nadeau is an expert in adult and pediatric allergy and asthma. Her research focuses on understanding the increased prevalence of allergies and asthma, improving diagnostics and the immunological mechanisms underlying these diseases. She was the first to successfully desensitize individuals to more than one allergy at a time using multi-allergen oral immunotherapy. She does clinical research to provide safe and effective therapeutic options for those with allergies and asthma.

OUR PARTNERS